Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
4.500
+0.330 (7.91%)
At close: Jun 26, 2026, 4:00 PM EDT
4.410
-0.090 (-2.00%)
After-hours: Jun 26, 2026, 7:38 PM EDT

Company Description

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally.

The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM).

It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures.

The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market.

It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019.

Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Apyx Medical Corporation
Apyx Medical logo
Country United States
Founded 1982
IPO Date Jan 1, 1987
Industry Medical Devices
Sector Healthcare
Employees 205
CEO Charles Goodwin

Contact Details

Address:
5115 Ulmerton Road
Clearwater, Florida 33760-4004
United States
Phone 727 384 2323
Website apyxmedical.com

Stock Details

Ticker Symbol APYX
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000719135
CUSIP Number 03849L108
ISIN Number US03837C1062
Employer ID 11-2644611
SIC Code 3841

Key Executives

Name Position
Charles D. Goodwin II President, Chief Executive Officer and Director
Matthew C. Hill CPA Chief Financial Officer, Treasurer and Secretary
Shawn D. Roman Chief Operating Officer
Moshe Citronowicz Senior Vice President
Dolores Catania Chief of Confidence

Latest SEC Filings

Date Type Title
Jun 26, 2026 DEF 14A Other definitive proxy statements
Jun 17, 2026 8-K Current Report
Jun 1, 2026 SD Form - SD
May 21, 2026 8-K Current Report
May 14, 2026 8-K Current Report
May 11, 2026 8-K Current Report
May 7, 2026 10-Q Quarterly Report
May 7, 2026 8-K Current Report
Mar 10, 2026 10-K Annual Report
Mar 10, 2026 8-K Current Report